Physician profile
Cheryl Moore
NPI 1861484289
$2,478.55
in general payments reported to CMS, 2019-2025
19 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $265 · 2021: $133 · 2022: $266 · 2023: $524 · 2024: $852 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,707.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $840.91 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $401.32 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $193.31 | 2023-2025 | |
| Inari Medical, INC. | $167.50 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lilly USA, LLC | $142.99 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $133.92 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Dexcom, INC. | $112.06 | 2024 | Dexcom G7 Gss (161) |
| Phadia US INC. | $104.51 | 2020 | |
| Gilead Sciences, INC. | $91.75 | 2019 | |
| Exact Sciences Corporation | $54.80 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $44.51 | 2022-2025 | Ozempic |
| Amgen INC. | $38.57 | 2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $32.62 | 2022 | |
| Lundbeck LLC | $23.60 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $21.30 | 2025 | Austedo Xr |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $20.87 | 2022 | |
| Neurocrine Biosciences, INC. | $20.40 | 2024 | Ingrezza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.89 | 2021 | |
| Cardiovascular Systems INC. | $14.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.